Jordan Tsai

Jordan Tsai is a Senior Scientist at Viridian Therapeutics, Inc., since May 2021, specializing in antibody discovery and engineering as well as CAR engineering. Previously, Jordan served as a Consultant and Scientist II at Kyverna Therapeutics from October 2019 to October 2022, focusing on similar areas. Prior to that, Jordan was a Research Investigator I in Protein Engineering at Bristol-Myers Squibb, where bispecific antibody engineering was the primary focus. Jordan's research journey began as a Graduate Student Researcher at the University of California, San Francisco, from September 2013 to April 2018, culminating in a Doctor of Philosophy (PhD) in Biochemistry and Molecular Biology in 2018. Jordan also gained foundational experience as a Research Assistant at the Energy Biosciences Institute from January 2010 to August 2013 and holds a B.S. in Chemical Biology and a B.A. in Molecular and Cell Biology from the University of California, Berkeley.